Babio Introduces Influenza A / B antigen celeri deprehendatur ornamentum

2025-09-24

Babio Introduces Influenza A / B antigen celeri deprehendatur ornamentum

TemporisInfluenza A et B VirusesManeat a major publicam valetudo minas terrarum, causing decies respiratorii infectiones per annum. Ad firmamentumFast et fideles influenza Diagnostics, Infans, A ducens Seres Manufacturer in Vitro Diagnostic solutions, nunc offertInfluenza A / B antigen Part Kit (Colloidal Aurum modum).

Celeri Dual Deprehensio de Influenza A et B

Hoclateralis fluxus immunoassaydatQualitative Deprehensio de Influenza A et B antigensin patientes estote exemplaria. In ornamentum features:

  • Dual Test Lines (T1 & T2)- Deprehendement Influenza A et Influenza B antigens.

  • Patet eventus in XV minutes- facile-ut-legere coloratum lineas ad ieiunium consilium-faciens.

  • Built-in potestate linea (C line)- ensures test validitatem omni currere.

  • Simplex workflow- Usus extraction quiddam et dropper, secundum applicationem, non Lab apparatu requiritur.

Global Relevance in Outbreak Control

Cum influenza mota nuntiavit inEuropa, North America, Africa et Southeast Asia, Celerique antigen deprehensio ludit a discrimine partes inFusce diagnosis, infectio imperium, et tumultus custodia. Babio est scriptor influenza A / B antigen Deprehensionem Ornamentum Offers Healthcare Suggests estreliable, punctum-of-cura toolad differentiam inter influenza A et B Infectiones.

De Babio

In MMIII condita;Infanscrevit in unum Sinis scriptor bene agnita manufacturersDiagnostic Reagents, celeri probat et microbial deprehendatur rhoncus. Cum iso-certified facilities et internationalis distribution, Babio continues providereinnovative, cost-effective solutionsNam global curis necessitates.

Disce magis de influenza a / b antigen deprehendatur ornamentum at:https://www.babiocorp.com.

#Influenza #flutest #rapidTesttkit #infectus A #Diagnostingtkit #RespiratoryHealth #PoInoFCare

X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept